From: A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France
No. biopsies
No. cancers:
No. high grade cancers:
Performed
Avoided
Found
Missed
Biopsy all men at risk
1000
0 (0%)
317
175
Biopsy if >= 20% risk from full model
508
492 (49%)
256
61 (19%)
163
12 (4%)